Cyclobenzaprine Hydrochloride Capsule, Extended Release
Product Images NDC 24979-036

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Cyclobenzaprine Hydrochloride (NDC 24979-036). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Upsher-smith Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 1

Chemical structure of Cyclobenzaprine Hydrochloride shown as a tricyclic ring system with a side chain including an amine group and a hydrochloride moiety.*

FDA Label Image

Image 2

An illustration showing a spoon holding a scoop of powder or granulated substance. The image is simple and black-and-white, likely intended as an instructional or representational graphic related to dosage or administration.*

FDA Label Image

Image 3

An instructional line drawing showing a hand holding a capsule labeled 'TOP,' demonstrating the orientation or handling of the capsule, likely for proper administration or usage guidance.*

FDA Label Image

15 (Image 4)

FDA Label Image

Image 5

Illustration showing a hand opening a capsule to pour its contents, consisting of small granules, into the palm of another hand. This demonstrates releasing powder from an extended-release capsule.*

FDA Label Image

Image 6

An instructional illustration showing a woman holding a spoon with medication, demonstrating oral administration, likely related to taking Cyclobenzaprine Hydrochloride extended release capsules.*

FDA Label Image

Image 7

An illustration showing a person drinking a glass of water, likely demonstrating the proper way to take an oral medication such as a capsule or tablet.*

FDA Label Image

Image 8

Label for Cyclobenzaprine Hydrochloride extended-release capsules, USP, 15 mg strength. The label indicates a package containing 60 capsules for oral use, labeled for prescription use only. It includes storage instructions, manufacturer information (TWI Pharmaceuticals, Taiwan and USA), and dosage guidance. The label features a barcode and NDC 24979-035-04.*

FDA Label Image

Image 9

Label for Cyclobenzaprine Hydrochloride Extended-Release Capsules, USP 30 mg, oral dosage form. The label shows a package of 60 capsules, manufactured by TWI Pharmaceuticals USA, Inc. Instructions for storage and usage warnings are partially visible, along with an NDC number 24979-036-04 and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.